Upload Avatar (500 x 500)
Zhao Fei Liu
Basic Medical Sciences
Peking University
Beijing
Language: Chinese, English
Molecular Imaging
Precision Medicine
Immunotherapy
Radiotherapy
Cancer Treatment
Radiopharmaceuticals
Clinical Trials
Nuclear Medicine
Therapeutic Innovation
Diagnostic Advancements
Areas of Focus
- Molecular imaging-guided precision immunotherapy/radiotherapy for cancer
- Development of novel radiopharmaceuticals overcoming clinical bottlenecks in nuclear medicine
Work Experience
- 2009 - Present: Peking University, Lecturer to Professor
Academic Background & Achievements
- 2004 - Bachelor of Medicine: Qingdao University Medical College
- 2009 - Doctor of Medicine: Peking University Medical Department
- Joint training at Stanford University School of Medicine Molecular Imaging Center during PhD
Publications
- Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy, Zhou H, Wang Y, Xu H, Shen X, Zhang T, Zhou X, Zeng Y, Li K, Zhang L, Zhu H, Yang X, Li N, Yang Z, Liu Z, 2022
- Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance, Lu D, Zhou H, Li N, Wang Y, Zhang T, Wang F, Liu N, Zhu H, Zhang J, Yang Z, Liu Z, 2022
- ICAM-1 orchestrates the abscopal effect of tumor radiotherapy, Zhao Y, Zhang T, Wang Y, Lu D, Du J, Feng X, Zhou H, Liu N, Zhu H, Qin S, Liu C, Gao X, Yang Z, Liu Z, 2021
- Clinical translation of a 68Ga-labeled integrin αvβ6-targeting cyclic radiotracer for PET imaging of pancreatic cancer, Feng X, Wang Y, Lu D, Xu X, Zhou X, Zhang H, Zhang T, Zhu H, Yang Z, Wang F, Li N, Liu Z, 2020
- Noninvasive PET tracking of post-transplant gut microbiota in living mice, Wang Y, Zhang C, Lai J, Zhao Y, Lu D, Bao R, Feng X, Zhang T, Liu Z, 2020
- Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy, Lai J, Lu D, Zhang C, Zhu H, Gao L, Wang Y, Bao R, Zhao Y, Jia B, Wang F, Yang Z, Liu Z, 2018
- Chemotherapy-induced macrophage infiltration into tumors enhances nanographene-based photodynamic therapy, Zhao Y, Zhang C, Gao L, Yu X, Lai J, Lu D, Bao R, Wang Y, Jia B, Wang F, Liu Z, 2017
- Inhibiting metastasis and preventing tumor relapse by triggering host immunity with tumor-targeted photodynamic therapy using photosensitizer-loaded functional nanographenes, Yu X, Gao D, Gao L, Lai J, Zhang C, Zhao Y, Zhong L, Jia B, Wang F, Chen X, Liu Z, 2017
- Enhanced anti-tumor efficacy through combination integrin αvβ6-targeted photodynamic therapy and immune checkpoint inhibition, Gao L, Liu H, Sun X, Gao D, Zhang C, Jia B, Zhu Z, Wang F, Liu Z, 2016
- Molecular imaging of post-Src-inhibition tumor signatures for guiding dasatinib combination therapy, Gao L, Zhang C, Gao D, Liu H, Yu X, Lai J, Wang F, Lin J, Liu Z, 2016
Awards
- 2012: National Natural Science Foundation of China First 'Excellent Young Scientist Fund'
- 2019: 'Beijing Outstanding Young Scientist Fund'
- 2023: National Natural Science Foundation of China 'National Outstanding Young Scientist Fund'
- 2008: SNMMI Berson-Yalow Award
- 2010: EANM Best Basic Research Paper Award
